Genentech Inc, a US biotechnology research company, plans to found a research joint venture with the Taiwanese government in Hsinchu to develop AIDS treatments headed by Taiwanese-American researcher David Ho (何大一), Chinese-language news-papers said yesterday.
Ho has reportedly agreed to serve as chairman of the planned joint-venture -- to be known as TaiMed -- which is to be set up in Hsinchu Biochemical Science Park (新竹生醫科學園區), reports quoted Liang Chi-ming (梁啟銘), director of the Office of Public Affairs at the Academia Sinica, as saying.
Academia Sinica is the nation's top research institute.
South San Francisco-based Genentech will transfer its CD4 antibody technology to TaiMed, the United Daily News said, citing Liang.
CD4, which exists on the membrane of T cells, is a primary receptor used by HIV-1 to gain entry into host T cells, which plays an essential role in cell-mediated immunity and targets of HIV infection. If developed successfully, the CD4 antibody will block CD4 from destroying the immune system.
Funding for the joint-venture should reach NT$3 billion (US$90.5 million) for the first three years, with the Cabinet's Development Fund investing in as much as 45 percent of that, the paper quoted Liang as saying. The rest of the funds will come from private enterprises and venture capital, the paper said.
The China Times carried a similar report yesterday, citing Council for Economic Planning and Development chairwoman Ho Mei-yueh (
But the government investment will not exceed 45 percent, or the company would become state-run, Ho said in the report.
Liang said that the project was initiated by Academia Sinica President Wong Chi-huey (翁啟惠), who hopes to establish a research firm to attract overseas Taiwanese biotech researchers back to the nation.
Ho, well-known for pioneering the use of protease inhibitors in treating HIV-infected patients with his team, will be hired as a researcher by the Academia Sinica and then assume the chairmanship of TaiMed, the reports said, quoting Liang.
The CD4 treatment, along with Ho's cocktail drug for curbing AIDS in its early period, will be the focus at TaiMed, Liang said.
If the new drug is successful, TaiMed could earn royalties from drug manufacturers and obtain sales right in East Asia, he said.
The legislature passed the Biotech and New Pharmaceutical Development Act (生技新藥產業發展條例) last Friday, which allows government researchers to transfer their knowledge to private companies developing new drugs.
The Eurovision Song Contest has seen a surge in punter interest at the bookmakers, becoming a major betting event, experts said ahead of last night’s giant glamfest in Basel. “Eurovision has quietly become one of the biggest betting events of the year,” said Tomi Huttunen, senior manager of the Online Computer Finland (OCS) betting and casino platform. Betting sites have long been used to gauge which way voters might be leaning ahead of the world’s biggest televised live music event. However, bookmakers highlight a huge increase in engagement in recent years — and this year in particular. “We’ve already passed 2023’s total activity and
Nvidia Corp CEO Jensen Huang (黃仁勳) today announced that his company has selected "Beitou Shilin" in Taipei for its new Taiwan office, called Nvidia Constellation, putting an end to months of speculation. Industry sources have said that the tech giant has been eyeing the Beitou Shilin Science Park as the site of its new overseas headquarters, and speculated that the new headquarters would be built on two plots of land designated as "T17" and "T18," which span 3.89 hectares in the park. "I think it's time for us to reveal one of the largest products we've ever built," Huang said near the
China yesterday announced anti-dumping duties as high as 74.9 percent on imports of polyoxymethylene (POM) copolymers, a type of engineering plastic, from Taiwan, the US, the EU and Japan. The Chinese Ministry of Commerce’s findings conclude a probe launched in May last year, shortly after the US sharply increased tariffs on Chinese electric vehicles, computer chips and other imports. POM copolymers can partially replace metals such as copper and zinc, and have various applications, including in auto parts, electronics and medical equipment, the Chinese ministry has said. In January, it said initial investigations had determined that dumping was taking place, and implemented preliminary
Intel Corp yesterday reinforced its determination to strengthen its partnerships with Taiwan’s ecosystem partners including original-electronic-manufacturing (OEM) companies such as Hon Hai Precision Industry Co (鴻海精密) and chipmaker United Microelectronics Corp (UMC, 聯電). “Tonight marks a new beginning. We renew our new partnership with Taiwan ecosystem,” Intel new chief executive officer Tan Lip-bu (陳立武) said at a dinner with representatives from the company’s local partners, celebrating the 40th anniversary of the US chip giant’s presence in Taiwan. Tan took the reins at Intel six weeks ago aiming to reform the chipmaker and revive its past glory. This is the first time Tan
RSS